Weight-loss drug Ozempic to help with substance abuse issues
Psychiatrist Sally Kelderman says people struggling with substance abuse could potentially benefit from weight-loss drug Ozempic.
'That's one of the fantastic, unexpected effects of Ozempic,' Dr Kelderman told Sky News host Sharri Markson.
'For people that are struggling from substance abuse, that could be really, really helpful.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News AU
2 days ago
- Sky News AU
Weight-loss drug Ozempic to help with substance abuse issues
Psychiatrist Sally Kelderman says people struggling with substance abuse could potentially benefit from weight-loss drug Ozempic. 'That's one of the fantastic, unexpected effects of Ozempic,' Dr Kelderman told Sky News host Sharri Markson. 'For people that are struggling from substance abuse, that could be really, really helpful.'
Sky News AU
2 days ago
- Sky News AU
Weight-loss drug Ozempic ‘intricately' involved in feelings of ‘desire' and ‘reward'
Psychiatrist Sally Kelderman discusses the weight-loss drug Ozempic. 'The current state of scientific thinking is that we have glucagon-like peptide receptors in our brains, naturally occurring – Ozempic works to enhance the effect of naturally occurring glucagon-like peptide,' Dr Kelderman told Sky News host Sharri Markson. 'And that is intricately involved in the experience of desire and reward in such a way that it dampens our sense of reward.'
Sky News AU
2 days ago
- Sky News AU
Consequences of weight-loss drug Ozempic revealed
Psychiatrist Sally Kelderman discusses the consequences of the weight-loss drug Ozempic. 'My perspective is very psychiatric – so, a lot of people who struggle with their weight or substance abuse are sad and unmotivated for many complex reasons,' Dr Kelderman told Sky News host Sharri Markson. 'If we're going to find people losing their sense of pleasure, we so need to watch out to see whether they're losing their desire to live. 'I'm expecting doctors will be asking people in the Ozempic receiving population whether they have any preexisting depression or thoughts of self-harm in any way.'
